A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, STRATIFIED, VEHICLE-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF SIROLIMUS 3.9% TOPICAL GEL IN PREVENTION OF BCCS IN PATIENTS WITH GORLIN SYNDROME